| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.41 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |